VANGUARD GROUP INC - CTI BIOPHARMA CORP ownership

CTI BIOPHARMA CORP's ticker is CTICXXXX and the CUSIP is 12648L106. A total of 87 filers reported holding CTI BIOPHARMA CORP in Q3 2015. The put-call ratio across all filers is 0.52 and the average weighting 0.0%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of CTI BIOPHARMA CORP
ValueSharesWeighting
Q4 2016$3,060,000
+11.0%
7,591,552
+3.1%
0.00%
Q3 2016$2,756,000
+6.1%
7,362,722
-3.6%
0.00%
Q2 2016$2,598,000
-41.3%
7,638,471
-8.3%
0.00%
Q1 2016$4,425,000
-45.8%
8,327,849
+25.4%
0.00%
-100.0%
Q4 2015$8,167,000
-96.8%
6,639,241
-64.1%
0.00%
-88.9%
Q3 2015$252,496,000
+2209.5%
18,502,626
+230.0%
0.01%
+800.0%
Q2 2015$10,933,000
+12.5%
5,606,669
+4.4%
0.00%0.0%
Q1 2015$9,722,000
-10.3%
5,370,846
+16.9%
0.00%0.0%
Q4 2014$10,839,000
+7.5%
4,592,711
+10.2%
0.00%0.0%
Q3 2014$10,085,000
-6.6%
4,167,379
+8.4%
0.00%0.0%
Q2 2014$10,803,0003,844,5790.00%
Other shareholders

There were no reported owners of CTI BIOPHARMA CORP in Q3 2015.

NameSharesValueWeighting ↓
View complete list of CTI BIOPHARMA CORP shareholders